If Pfizer causes fever, that would mean it is very effective. For the appropriate dosage, it is always a balance between effectiveness and side effects.
Do you know what high fever mean for kids? High fever for kids can be deadly. That's why Pfizer is forced to test 3 doses for kids because high fever is not acceptable for kids.
48 percent for Pfizer vs 64.6 percent for Sinovac for preventing hospitalizations. Sinovac's performance in kids is much better than Pfizer after Pfizer gives kids with 10 micrograms. As for 3 micrograms Pfizer vaccine is basically useless.
The vaccine’s effectiveness against hospitalization declined to 73 percent from 85 percent in the older children. In the younger children, effectiveness dropped to
48 percent from 100 percent. But because few children were hospitalized, these estimates have wide margins of error.
The numbers for protection from infection are more reliable. Vaccine effectiveness against infection in the older children decreased to
51 percent from 66 percent. But in the younger children, it dropped sharply to just
12 percent from 68 percent.
The submission was surprising because in December the companies said early trial results of the two low doses of the vaccine fell short of expectations, and it amended its clinical trial to test a three-dose version.
China-based Sinovac Biotech Ltd's
COVID-19 vaccine was 38.2% effective in preventing infections during the Omicron wave in children aged three to five years, a study in Chile showed.
The findings are in contrast to earlier studies that showed the vaccine, CoronaVac,
was 74.5% effective in preventing infections in children aged 6 to 16 years, when Delta was the dominant variant.
Countries are increasingly recommending booster doses in the face of the circulating Omicron variant, which the World Health Organization has said can bypass some protection imparted by vaccines. Most vaccines are still effective against severe infections.
Sinovac's vaccine was 64.6% effective in preventing hospitalizations and 69% effective in preventing COVID-19 related ICU admissions, the Chilean study also showed.